scispace - formally typeset
Open AccessJournal ArticleDOI

The biology of cancer: metabolic reprogramming fuels cell growth and proliferation

Reads0
Chats0
TLDR
This review examines the idea that several core fluxes, including aerobic glycolysis, de novo lipid biosynthesis, and glutamine-dependent anaplerosis, form a stereotyped platform supporting proliferation of diverse cell types and regulates regulation of these fluxes by cellular mediators of signal transduction and gene expression.
About
This article is published in Cell Metabolism.The article was published on 2008-01-01 and is currently open access. It has received 3526 citations till now. The article focuses on the topics: PI3K/AKT/mTOR pathway & Lipid biosynthesis.

read more

Citations
More filters
Journal ArticleDOI

ACLY facilitates colon cancer cell metastasis by CTNNB1

TL;DR: Immunohistochemical analysis of 78 colon cancer patients showed that the high expression levels of ACLY and CTNNB1 protein was positively correlated with metastasis of colon cancer, shedding new light on the molecular mechanism underlying colon cancer metastasis, which might help in improving therapeutic efficacy.
Journal ArticleDOI

Endothelial cell metabolism: parallels and divergences with cancer cell metabolism

TL;DR: These studies show that metabolic pathways in endothelial cells (ECs) importantly regulate angiogenesis in conjunction with genetic signals, and emerging insights in EC metabolism are highlighted and discussed in perspective of cancer cell metabolism.
Journal ArticleDOI

Light Exposure at Night Disrupts Host/Cancer Circadian Regulatory Dynamics: Impact on the Warburg Effect, Lipid Signaling and Tumor Growth Prevention

TL;DR: It is determined that circulating systemic factors in the host and the Warburg effect, linoleic acid uptake/metabolism and growth signaling activities in the tumor are dynamically regulated, coordinated and integrated within circadian time structure over a 24-hour light/dark cycle by SCN-driven nocturnal pineal production of the anticancer hormone melatonin.
Journal ArticleDOI

p53 and metabolism: from mechanism to therapeutics.

TL;DR: The interplay between p53 and metabolism is essential in the decision of cell fate and for cancer therapeutics and drugs that target metabolism may have different outcomes and metabolism may modulate drug resistance.
Journal ArticleDOI

The metabolic landscape of RAS-driven cancers from biology to therapy

TL;DR: Mukhopadhyay et al. as mentioned in this paper discuss the metabolic reprogramming mediated by oncogenic RAS in cancer and elucidate the underlying mechanisms that could translate to novel therapeutic opportunities to target metabolic vulnerabilities in RAS-driven cancers.
References
More filters
Journal ArticleDOI

On the origin of cancer cells.

Journal ArticleDOI

Targeting HIF-1 for cancer therapy

TL;DR: Hypoxia-inducible factor 1 (HIF-1) activates the transcription of genes that are involved in crucial aspects of cancer biology, including angiogenesis, cell survival, glucose metabolism and invasion.
Journal ArticleDOI

HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia

TL;DR: A hypoxia-induced metabolic switch that shunts glucose metabolites from the mitochondria to glycolysis to maintain ATP production and to prevent toxic ROS production is revealed.